Terms: = Colorectal cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Prognosis
2659 results:
1. Characterization of the prognostic, diagnostic, and immunological roles of DSCC1 and its genomic alteration and instability in human cancers.
Liu H; Cui Z; Wang R; Wang L; Wang L; Cheng F; Pan R; Yang X
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):202-211. PubMed ID: 38678604
[TBL] [Abstract] [Full Text] [Related]
2. Genetic and microbial determinants of azoxymethane-induced colorectal tumor susceptibility in Collaborative Cross mice and their implication in human cancer.
Li D; Zhong C; Yang M; He L; Chang H; Zhu N; Celniker SE; Threadgill DW; Snijders AM; Mao JH; Yuan Y
Gut Microbes; 2024; 16(1):2341647. PubMed ID: 38659246
[TBL] [Abstract] [Full Text] [Related]
3. Critical roles of long noncoding RNA H19 in cancer.
Darmadi D; Chugaeva UY; Saleh RO; Hjazi A; Saleem HM; Ghildiyal P; Alwaily ER; Alawadi A; Alnajar MJ; Ihsan A
Cell Biochem Funct; 2024 Apr; 42(3):e4018. PubMed ID: 38644608
[TBL] [Abstract] [Full Text] [Related]
4. The role of piRNAs in predicting and prognosing in cancer: a focus on piRNA-823 (a systematic review and meta-analysis).
Taghizadeh M; Jafari-Koshki T; Jafarlou V; Raeisi M; Alizadeh L; Roosta Y; Matin S; Jabari R; Sur D; Karimi A
BMC Cancer; 2024 Apr; 24(1):484. PubMed ID: 38627675
[TBL] [Abstract] [Full Text] [Related]
5. Unveiling intratumoral microbiota: An emerging force for colorectal cancer diagnosis and therapy.
Zhang J; Wang P; Wang J; Wei X; Wang M
Pharmacol Res; 2024 May; 203():107185. PubMed ID: 38615875
[TBL] [Abstract] [Full Text] [Related]
6. Lectin-Based Immunophenotyping and Whole Proteomic Profiling of CT-26 Colon Carcinoma Murine Model.
Faragó A; Zvara Á; Tiszlavicz L; Hunyadi-Gulyás É; Darula Z; Hegedűs Z; Szabó E; Surguta SE; Tóvári J; Puskás LG; Szebeni GJ
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612832
[TBL] [Abstract] [Full Text] [Related]
7. ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.
Huang Y; Chen D; Bai Y; Zhang Y; Zheng Z; Fu Q; Yi B; Jiang Y; Zhang Z; Zhu J
BMC Cancer; 2024 Apr; 24(1):452. PubMed ID: 38605349
[TBL] [Abstract] [Full Text] [Related]
8. The HLA-I landscape confers prognosis and antitumor immunity in breast cancer.
Ding XH; Xiao Y; Chen F; Liu CL; Fu T; Shao ZM; Jiang YZ
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38602320
[TBL] [Abstract] [Full Text] [Related]
9. The dawn of a new Era: mRNA vaccines in colorectal cancer immunotherapy.
Song J; Zhang Y; Zhou C; Zhan J; Cheng X; Huang H; Mao S; Zong Z
Int Immunopharmacol; 2024 May; 132():112037. PubMed ID: 38599100
[TBL] [Abstract] [Full Text] [Related]
10. A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells.
Fonseca P; Cui W; Struyf N; Tong L; Chaurasiya A; Casagrande F; Zhao H; Fernando D; Chen X; Tobin NP; Seashore-Ludlow B; Lundqvist A; Hartman J; Göndör A; Östling P; Holmgren L
J Exp Clin Cancer Res; 2024 Apr; 43(1):107. PubMed ID: 38594748
[TBL] [Abstract] [Full Text] [Related]
11. Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer.
Mouillet-Richard S; Gougelet A; Passet B; Brochard C; Le Corre D; Pitasi CL; Joubel C; Sroussi M; Gallois C; Lavergne J; Castille J; Vilotte M; Daniel-Carlier N; Pilati C; de Reyniès A; Djouadi F; Colnot S; André T; Taieb J; Vilotte JL; Romagnolo B; Laurent-Puig P
J Transl Med; 2024 Apr; 22(1):337. PubMed ID: 38589873
[TBL] [Abstract] [Full Text] [Related]
12. Mechanistic insights into FEN1-mediated drug sensitivity and risk signature in colon cancer: An integrative bioinformatics study.
Rao C; Tong J; Yang Y
Medicine (Baltimore); 2024 Mar; 103(13):e37517. PubMed ID: 38552056
[TBL] [Abstract] [Full Text] [Related]
13. CD8-positive T Cell Infiltration With Human Leukocyte Antigen Class 1 Expression Predicts Patients With Stage IV colorectal cancer Survival.
Satoyoshi T; Hirohashi Y; Okuya K; Miyo M; Akizuki E; Ishii M; Miura R; Kubo T; Murata K; Kanaseki T; Tsukahara T; Takemasa I; Torigoe T
Anticancer Res; 2024 Apr; 44(4):1603-1610. PubMed ID: 38537969
[TBL] [Abstract] [Full Text] [Related]
14. Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer.
Zhang D; Xie J; Sun F; Xu R; Liu W; Xu J; Huang X; Zhang G
Cancer Lett; 2024 May; 589():216819. PubMed ID: 38522775
[TBL] [Abstract] [Full Text] [Related]
15. A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche.
Zepeda-Rivera M; Minot SS; Bouzek H; Wu H; Blanco-Míguez A; Manghi P; Jones DS; LaCourse KD; Wu Y; McMahon EF; Park SN; Lim YK; Kempchinsky AG; Willis AD; Cotton SL; Yost SC; Sicinska E; Kook JK; Dewhirst FE; Segata N; Bullman S; Johnston CD
Nature; 2024 Apr; 628(8007):424-432. PubMed ID: 38509359
[TBL] [Abstract] [Full Text] [Related]
16. Identification of expression profiles and prognostic value of RFCs in colorectal cancer.
Misbah M; Kumar M; Najmi AK; Akhtar M
Sci Rep; 2024 Mar; 14(1):6607. PubMed ID: 38504096
[TBL] [Abstract] [Full Text] [Related]
17. Decreased interleukin-17RA expression is associated with good prognosis in patients with colorectal cancer and inhibits tumor growth and vascularity in mice.
Jiang JK; Lin CH; Chang TA; Lo LC; Lin CP; Lu RH; Yang CY
Cancer Med; 2024 Mar; 13(5):e7059. PubMed ID: 38491831
[TBL] [Abstract] [Full Text] [Related]
18. FSHing for DNA Damage: Key Features of MutY Detection of 8-Oxoguanine:Adenine Mismatches.
Majumdar C; Demir M; Merrill SR; Hashemian M; David SS
Acc Chem Res; 2024 Apr; 57(7):1019-1031. PubMed ID: 38471078
[TBL] [Abstract] [Full Text] [Related]
19. Exploring the potential biological function of GRK2 in colorectal cancer.
Gao M; Liang X; Fan M; Wu Y; Dong MY; Du RL
Funct Integr Genomics; 2024 Mar; 24(2):51. PubMed ID: 38446273
[TBL] [Abstract] [Full Text] [Related]
20. HER2 targeted therapy in colorectal cancer: Current landscape and future directions.
Chen N; He L; Zou Q; Deng H
Biochem Pharmacol; 2024 May; 223():116101. PubMed ID: 38442793
[TBL] [Abstract] [Full Text] [Related]
[Next]
